The association between HIV infection, antiretroviral therapy and cervical squamous intraepithelial lesions in South Western Nigerian women

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ezechi, Oliver Chukwujekwu ^a,b   Pettersson, Karen Odberg ^b   Okolo, Clement Abu ^c   Ujah, Innocent Achaya O ^a   Ostergren, Per Olof ^b  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CERVICAL SQUAMOUS INTRAEPITHELIAL LESION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NIGERIA; PREVALENCE; RISK ASSESSMENT; RISK REDUCTION; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VIRUS LOAD; COMPLICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; PATHOLOGY; SOCIAL CLASS; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; VAGINA SMEAR;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; MIDDLE AGED; NIGERIA; SOCIAL CLASS; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; VAGINAL SMEARS;

EID: 84901501829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097150     Document Type: Article

References (36)

1. th May 2010. Abstract number TuOrC02; 04.
2. Shah RM, Bulgiba A, Lee CKC, Haniff J, Ali MM (2012) Highly active antiretoviral therapy reduces mortality and morbidity in patients with AIDS in Songai Balot Hospital Journal of Experimental and Clinical Medicine 4(4): 239-244.
3. Jevtović D, Dragovićs G, Salemović D, Ranin J, Kušić J, et al (2014) Treatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Study. Biomed Pharmacother S0753-3322(14)00004-3. doi:10.1016/j.biopha.2014.01.001.
4. Bernstein WB, Little RF, Wilson WH, Yarchoan R (2006) Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. Int J Hematol 84(1): 3-11. (Pubitemid 44756769)
5. Adler DH (2010) The impact of HAART on HPV-related cervical disease. Curr HIV Res 8(7): 493-7.
6. Gates AE, Kaplan LD (2002) AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Williston Park) 16(5): 657-65.
7. Odida M, Sandin S, Mirembe F, Kleter B, Quint W, et al (2011) HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study. Infectious Agents and Cancer 6: 8. Available: http://www. infectagentscancer.com/content/6/1/8.
8. ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, et al (1992) Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. Int J Cancer 51: 515-521.
9. Schmauz R, Okong P, de Villiers EM, Dennin R, Brade L, (1989) Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 43: 805-809. (Pubitemid 19138185)
10. Sekirime WK, Gray R (2007) HIV infection among Uganda women with cervical cancer: a retrospective study. Gynecol Obstet Invest 63: 222-228. (Pubitemid 46742310)
11. Kahesa C, Mwaiselage J, Wabinga HR, Ngoma T, Kalyango JN, et al (2008) Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BMC Public Health 8: 262.
12. Firnhaber C, Westreich D, Schulze D, Williams S, Siminya M, et al (2012) Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa. J Int AIDS Soc 15(2): 17382.
13. Zeier MD, Botha MH, van der M, Frederick H, Eshun-Wilson I, et al (2012) Progression and Persistence of Low-Grade Cervical Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus. Journal of Lower Genital Tract Disease 16(3): 243-250.
14. Xi LF, Kivat NB (2005) Cervical neoplasia and highly active antiretroviral therapy. Journal of the National Cancer Institute 96 (14): 1051-1054.
15. Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, et al (2013) Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis. 20138(3): 454-62.
16. Chen YC, Li CY, Liu HY, Lee NY, Ko WC, et al (2013) Effect of antiretroviral therapy on the incidence of cervical neoplasia among HIV-infected women: a population-based cohort study in Taiwan. AID Dec 10. [Epub ahead of print]. Available: http://www.ncbi.nlm.nih.gov/pubmed/24326354.
17. McKenzie KP, Rogers RK, Njoroge JW, John-Stewart G, Richardson BA, et al (2011) Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya. Curr HIV Res 9(3): 180-5.
18. Mogtomo ML, Malieugoue LC, Djiepgang C, Wankam M, Moune A, et al (2009) Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy. Infect Agent Cancer. 3: 4: 9. doi:10.1186/1750-9378-4-9.
19. Agaba PA, Thacher TD, Ekwempu CC, Idoko JA (2009) Cervical dysplasia in Nigerian women Infected with HIV. International Journal of Gynecology and Obstetrics 107: 99-102.
20. Chama CM, Nggada H, Gaushau W (2005) Cervical dysplasia in HIV infected women in Maiduguri, Nigerian Journal of Obstetrics and Gynaecology 25(3): 286-288. (Pubitemid 43187025)
21. Akinwuntan AL, Adesina OA, Okolo CA, Oluwasola OA, Oladokun O, et al (2008) Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women. Journal of Obstetrics and Gynaecology 28(6): 638-641.
22. Swende TZ, Ngwan SD, Swende LT (2012) Prevalence and risk factors for cervical squamous intraepithelial lesions among women infected with HIV-1 in Makurdi, Nigeria. International Journal of Women's Health 4: 55-60.
23. Anorlu RI, Abdul-Kareem FB, Abudu OO, Oyekan TO (2003) Cervical cytology in an urban population in Lagos, Nigeria. J Obstet Gynaecol 23(3): 285-8. (Pubitemid 36735072)
24. Durowade KA, Osagbemi GK, Salaudeen AG, Musa OI, Akande TM, et al (2012) Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria. J Prev Med Hyg 53(4): 213-9.
25. Pimentel VM, Jiang X, Mandavilli S, Umenyi N C, Schnatz PF (2013)Prev-Prevalence of high-risk cervical human papillomavirus and squamous intraepithelial lesion in Nigeria. J Low Genit Tract Dis. 17(2): 203-9.
26. Davey DD (2003). Cervical cytology classification and Bethesda system. The Cancer Journal 9(5): 327-334.
27. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, et al (2005) Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586. (Pubitemid 40723785)
28. Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IA, Odberg Pettersson K (2014) The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virology Journal; 11: 5. doi:10.1186/1743-422X-11-5.
29. Banura C, Franceschi S, van Doorn L, Arslan A, Wabwire-Mangen F, et al (2008) Infection with Human Papillomavirus and HIV among Young Women in Kampala, Uganda. The Journal of Infectious Diseases 194(4): 555-562. (Pubitemid 351321533)
30. Odida M, de Sanjosé S, Quint W, Bosch XF, Klaustermeier J, et al (2008) Human Papillomavirus type distribution in invasive cervical cancer in Uganda. BMC Infectious Diseases 8: 85. doi:10.1186/1471-2334-8-85.
31. Anorlu RI, Igwilo CI, Akanmu AS, Banjo AA, Odunukwe NN, et al (2007) Prevalence of abnormal cervical smears among patients with HIV in Lagos, Nigeria. West Afr J Med. 26(2): 143-7. (Pubitemid 47490442)
32. Chalermchockcharoenkit A, Srimai K, Chaisilwattana P (2006) High prevalence of cervical squamous cell abnormalities among HIV-infected women with immunological AIDS-defining illnesses. J Obstet Gynaecol Res 32: 324-329. (Pubitemid 43800426)
33. Lehtovirta P, Paavonen J, Heikinheimo O (2008) Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women. Int J STD AIDS 19: 37-41. (Pubitemid 351738841)
34. National Agency for the control of AIDS (2011). Antiretroviral therapy in Nigeria. Available: http://www.naca.gov.ng/content/view/417/language,en/.
35. Ezechi OC, Gab-Okafor CV, Ostergren PO, Odberg Pettersson K (2013) Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women. BMC Public Health 2013 13: 46 doi:10.1186/1471-2458-13-46.
36. WHO (2008). Task shifting: rational redistribution of tasks among health workforce teams: global recommendations and guidelines. WHO Geneva.